Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „CYP3A4“
Suchtreffer
Begriffe & Kennungen
Abilify Maintena · 4.5 · 29 Following concomitant administration of carbamazepine, a strong inducer of CYP3A4, and oral aripiprazole to
Eintrag öffnenAbilify Maintena · 4.5 · Carbamazepine and other CYP3A4 inducers
Eintrag öffnenAbilify Maintena · 4.5 · Carbamazepine and other CYP3A4 inducers Following concomitant administration of carbamazepine, a strong induce
Eintrag öffnenAbilify Maintena · 4.5 · Ketoconazole and other strong CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects,
Eintrag öffnenAbilify Maintena · 4.5 · Ketoconazole and other strong CYP3A4 inhibitors In a clinical trial of oral aripiprazole in healthy subjects,
Eintrag öffnenAbiraterone Mylan · 4.5 · Strong inducers of CYP3A4 (e.g., phenytoin, carbamazepine, rifampicin, rifabutin, rifapentine, phenobarbital,
Eintrag öffnenAbraxane · 4.5 · The metabolism of paclitaxel is catalysed, in part, by cytochrome P450 isoenzymes CYP2C8 and CYP3A4 (see secti
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin with ketoconazole, a strong CYP3A4 and P-gp inhibitor, increased the
Eintrag öffnenAdcetris · 4.5 · Co-administration of brentuximab vedotin with rifampicin, a strong CYP3A4 inducer, did not alter the plasma ex
Eintrag öffnenAdcetris · 4.5 · Co-administration of midazolam, a CYP3A4 substrate, with brentuximab vedotin did not alter the metabolism of m
Eintrag öffnenAdcetris · 4.5 · Interaction with medicinal products metabolised through CYP3A4 route (CYP3A4 inhibitors/inducers)
Eintrag öffnenAdempas · 4.5 · Concomitant use with CYP3A4 inducers Bosentan, reported to be a moderate inducer of CYP3A4, led to a decrease
Eintrag öffnenAdempas · 4.5 · Concomitant use with CYP3A4 inducers Bosentan, reported to be a moderate inducer of CYP3A4, led to a decrease
Eintrag öffnenAdempas · 4.5 · Riociguat is cleared mainly via cytochrome P450-mediated (CYP1A1, CYP3A4, CYP3A5, CYP2J2) oxidative metabolism
Eintrag öffnenAdempas · 4.5 · Riociguat is cleared mainly via cytochrome P450-mediated (CYP1A1, CYP3A4, CYP3A5, CYP2J2) oxidative metabolism
Eintrag öffnenAdempas · 4.5 · The concomitant use of riociguat with strong CYP3A4 inducers (e.g. phenytoin, carbamazepine, phenobarbitone or
Eintrag öffnenAdempas · 4.5 · The concomitant use of riociguat with strong CYP3A4 inducers (e.g. phenytoin, carbamazepine, phenobarbitone or
Eintrag öffnenAdvagraf · 4.5 · Effect of tacrolimus on the metabolism of other medicinal products Tacrolimus is a known CYP3A4 inhibitor; thu
Eintrag öffnenAdvagraf · 4.5 · Metabolic interactions Systemically available tacrolimus is metabolised by hepatic CYP3A4. There is also evide
Eintrag öffnenAkeega · 4.5 · Effects of other medicinal products on niraparib or abiraterone acetate CYP3A4 inducers and inhibitors Abirate
Eintrag öffnen